European Medicines Agency Plans Major Revision of Pharmacogenomic Practice Guidelines
Rapid Read

European Medicines Agency Plans Major Revision of Pharmacogenomic Practice Guidelines

What's Happening? The European Medicines Agency (EMA) is set to revise its 2018 guideline on good pharmacogenomic practice. This update, outlined in a Concept paper by the Committee for Medicinal Products for Human Use (CHMP), aims to incorporate rapid scientific advancements and emerging regulatory
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.